Rank | Gene Set | Z-score |
---|---|---|
1 | N-acetylneuraminate metabolic process (GO:0006054) | 5.20395644 |
2 | amino sugar catabolic process (GO:0046348) | 5.20156796 |
3 | negative regulation of interleukin-12 production (GO:0032695) | 5.01553186 |
4 | microglial cell activation (GO:0001774) | 4.92312301 |
5 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.73614277 |
6 | positive regulation of chemokine secretion (GO:0090197) | 4.63178077 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.62750449 |
8 | modulation by symbiont of host defense response (GO:0052031) | 4.62750449 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.62750449 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.62750449 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.62750449 |
12 | modulation by symbiont of host immune response (GO:0052553) | 4.62750449 |
13 | glycosphingolipid catabolic process (GO:0046479) | 4.32839191 |
14 | immunoglobulin mediated immune response (GO:0016064) | 4.31109392 |
15 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.29626377 |
16 | regulation of mononuclear cell migration (GO:0071675) | 4.26195831 |
17 | regulation of macrophage chemotaxis (GO:0010758) | 4.15647255 |
18 | barbed-end actin filament capping (GO:0051016) | 4.08123683 |
19 | negative regulation of mast cell activation (GO:0033004) | 3.99455390 |
20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97335771 |
21 | superoxide anion generation (GO:0042554) | 3.95539267 |
22 | regulation of chemokine secretion (GO:0090196) | 3.94081758 |
23 | ceramide catabolic process (GO:0046514) | 3.82906961 |
24 | glycolipid catabolic process (GO:0019377) | 3.82337193 |
25 | detection of external biotic stimulus (GO:0098581) | 3.75532954 |
26 | macrophage differentiation (GO:0030225) | 3.68507167 |
27 | response to peptidoglycan (GO:0032494) | 3.68231778 |
28 | * positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.64911711 |
29 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.60856292 |
30 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.60444014 |
31 | * regulation of leukocyte degranulation (GO:0043300) | 3.58212519 |
32 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.54890300 |
33 | oligosaccharide catabolic process (GO:0009313) | 3.54504429 |
34 | T-helper 1 type immune response (GO:0042088) | 3.52777146 |
35 | neutrophil activation involved in immune response (GO:0002283) | 3.52244551 |
36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.52017778 |
37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.51111242 |
38 | macrophage activation involved in immune response (GO:0002281) | 3.50690811 |
39 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.49581195 |
40 | regulation of activation of Janus kinase activity (GO:0010533) | 3.45310782 |
41 | * regulation of mast cell activation (GO:0033003) | 3.44259776 |
42 | cellular response to exogenous dsRNA (GO:0071360) | 3.42578989 |
43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.41196728 |
44 | negative regulation of cell killing (GO:0031342) | 3.41196728 |
45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39091080 |
46 | response to host immune response (GO:0052572) | 3.39091080 |
47 | * regulation of mast cell activation involved in immune response (GO:0033006) | 3.36173191 |
48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35973043 |
49 | * regulation of mast cell degranulation (GO:0043304) | 3.35294509 |
50 | macrophage activation (GO:0042116) | 3.32280501 |
51 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.31855480 |
52 | response to thyroid hormone (GO:0097066) | 3.31352284 |
53 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.29192443 |
54 | response to acidic pH (GO:0010447) | 3.27249434 |
55 | detection of biotic stimulus (GO:0009595) | 3.26589451 |
56 | phagosome maturation (GO:0090382) | 3.23038422 |
57 | dendritic cell chemotaxis (GO:0002407) | 3.21458437 |
58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20804615 |
59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20267967 |
60 | mannose metabolic process (GO:0006013) | 3.18991956 |
61 | positive regulation of defense response to virus by host (GO:0002230) | 3.18873844 |
62 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.17784206 |
63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15775365 |
64 | respiratory burst (GO:0045730) | 3.10657853 |
65 | neutrophil activation (GO:0042119) | 3.08570250 |
66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05673076 |
67 | lytic vacuole organization (GO:0080171) | 3.05310758 |
68 | lysosome organization (GO:0007040) | 3.05310758 |
69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05241375 |
70 | regulation of antigen processing and presentation (GO:0002577) | 3.04549292 |
71 | lipoxygenase pathway (GO:0019372) | 3.04211096 |
72 | response to muramyl dipeptide (GO:0032495) | 3.03512726 |
73 | response to host (GO:0075136) | 3.02491356 |
74 | response to host defenses (GO:0052200) | 3.02491356 |
75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02491356 |
76 | B cell mediated immunity (GO:0019724) | 3.02244489 |
77 | nucleotide transmembrane transport (GO:1901679) | 3.02235452 |
78 | mast cell activation (GO:0045576) | 3.01433332 |
79 | positive regulation of phagocytosis (GO:0050766) | 2.99381431 |
80 | apoptotic cell clearance (GO:0043277) | 2.98545349 |
81 | dendritic cell migration (GO:0036336) | 2.98119756 |
82 | regulation of superoxide anion generation (GO:0032928) | 2.96759223 |
83 | myeloid cell activation involved in immune response (GO:0002275) | 2.95794384 |
84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95696971 |
85 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.93386658 |
86 | positive regulation of interferon-alpha production (GO:0032727) | 2.91048163 |
87 | regulation of T cell tolerance induction (GO:0002664) | 2.89500696 |
88 | cellular response to interferon-beta (GO:0035458) | 2.87845964 |
89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86947041 |
90 | virion attachment to host cell (GO:0019062) | 2.86719228 |
91 | adhesion of symbiont to host cell (GO:0044650) | 2.86719228 |
92 | pinocytosis (GO:0006907) | 2.84522285 |
93 | energy homeostasis (GO:0097009) | 2.84271250 |
94 | granulocyte activation (GO:0036230) | 2.84187586 |
95 | detection of other organism (GO:0098543) | 2.83849710 |
96 | * regulation of regulated secretory pathway (GO:1903305) | 2.81489380 |
97 | * positive regulation of leukocyte degranulation (GO:0043302) | 2.80973873 |
98 | sphingolipid catabolic process (GO:0030149) | 2.80283548 |
99 | positive regulation of T cell migration (GO:2000406) | 2.80111972 |
100 | actin filament polymerization (GO:0030041) | 2.79369800 |
101 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.78472423 |
102 | * positive regulation of mast cell degranulation (GO:0043306) | 2.76926696 |
103 | * positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76926696 |
104 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76200022 |
105 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75832367 |
106 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.75421652 |
107 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.74751452 |
108 | regulation of interferon-alpha production (GO:0032647) | 2.74526953 |
109 | adhesion of symbiont to host (GO:0044406) | 2.72807939 |
110 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.72416289 |
111 | regulation of phagocytosis (GO:0050764) | 2.71383993 |
112 | positive regulation of interleukin-17 production (GO:0032740) | 2.69090600 |
113 | positive regulation of lymphocyte migration (GO:2000403) | 2.68022415 |
114 | negative regulation of phagocytosis (GO:0050765) | 2.66942603 |
115 | myeloid leukocyte activation (GO:0002274) | 2.66196183 |
116 | negative regulation of granulocyte differentiation (GO:0030853) | 2.66169692 |
117 | detection of molecule of bacterial origin (GO:0032490) | 2.63927011 |
118 | regulation of monocyte chemotaxis (GO:0090025) | 2.60788006 |
119 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.57831611 |
120 | cellular extravasation (GO:0045123) | 2.55887791 |
121 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.55728163 |
122 | * G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.54862969 |
123 | leukocyte degranulation (GO:0043299) | 2.52156086 |
124 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.51030088 |
125 | superoxide metabolic process (GO:0006801) | 2.49094801 |
126 | myeloid dendritic cell activation (GO:0001773) | 2.48920397 |
127 | natural killer cell activation involved in immune response (GO:0002323) | 2.47605511 |
128 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.47312483 |
129 | negative regulation of myoblast differentiation (GO:0045662) | 2.47223782 |
130 | interferon-gamma production (GO:0032609) | 2.46881985 |
131 | regulation of T cell migration (GO:2000404) | 2.45145506 |
132 | eosinophil chemotaxis (GO:0048245) | 2.44244762 |
133 | detection of bacterium (GO:0016045) | 2.43805697 |
134 | regulation of lymphocyte migration (GO:2000401) | 2.42478132 |
135 | * positive regulation of mast cell activation (GO:0033005) | 2.42364639 |
136 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.41577974 |
137 | * purinergic receptor signaling pathway (GO:0035587) | 2.41555109 |
138 | regulation of hypersensitivity (GO:0002883) | 2.41400509 |
139 | membrane lipid catabolic process (GO:0046466) | 2.37966718 |
140 | phagocytosis, engulfment (GO:0006911) | 2.37851007 |
141 | leukotriene metabolic process (GO:0006691) | 2.36946910 |
142 | GPI anchor biosynthetic process (GO:0006506) | 2.36839746 |
143 | cyclooxygenase pathway (GO:0019371) | 2.35043604 |
144 | regulation of interleukin-17 production (GO:0032660) | 2.33810892 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.42125554 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.26455687 |
3 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.02240006 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69490545 |
5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.46726817 |
6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.32238047 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26213691 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.05780162 |
9 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.79505301 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.60692730 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59087078 |
12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.58892249 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47978723 |
14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.35938906 |
15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.33246522 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27326693 |
17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23777947 |
18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23774490 |
19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.16274561 |
20 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.14398709 |
21 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.05075844 |
22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.04511263 |
23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03288758 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95535132 |
25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.91608769 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90950097 |
27 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.90642862 |
28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84695808 |
29 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82178690 |
30 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.80537621 |
31 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78757879 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78139080 |
33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77156514 |
34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76217233 |
35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75941284 |
36 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.75412329 |
37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.74117685 |
38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73116738 |
39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71756876 |
40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68959692 |
41 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.67849184 |
42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64909177 |
43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.62606813 |
44 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.60997508 |
45 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.60925492 |
46 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59571658 |
47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.58102568 |
48 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.55626179 |
49 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.53405905 |
50 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53181837 |
51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52891309 |
52 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52828854 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52553174 |
54 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.50691276 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49505032 |
56 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.49206890 |
57 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.48829631 |
58 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.46615333 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46480490 |
60 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.44942251 |
61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43787164 |
62 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.43279805 |
63 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.42915305 |
64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41961891 |
65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41631501 |
66 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.39481530 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39255812 |
68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38490862 |
69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36619221 |
70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34785788 |
71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34281638 |
72 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.33436640 |
73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32335995 |
74 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.32273347 |
75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32066514 |
76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31330823 |
77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31130136 |
78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31073845 |
79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30600356 |
80 | MAF_26560356_Chip-Seq_TH1_Human | 1.30218030 |
81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29962143 |
82 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.29446614 |
83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29048445 |
84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28768681 |
85 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.28077797 |
86 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28050389 |
87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27278299 |
88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27058492 |
89 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26712879 |
90 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.24656546 |
91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22986485 |
92 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21727136 |
93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21410618 |
94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20935422 |
95 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19909869 |
96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18741431 |
97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17947790 |
98 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.17444690 |
99 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16007314 |
100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15617260 |
101 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13086614 |
102 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.12922838 |
103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12708733 |
104 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12332651 |
105 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11976012 |
106 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11656313 |
107 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11499261 |
108 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11043558 |
109 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10296997 |
110 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10154304 |
111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09924109 |
112 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08835956 |
113 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08659185 |
114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08452175 |
115 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07182919 |
116 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07143852 |
117 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06786616 |
118 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06152288 |
119 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05628036 |
120 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05161154 |
121 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04152214 |
122 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03824377 |
123 | MAF_26560356_Chip-Seq_TH2_Human | 1.03649562 |
124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03443207 |
125 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03140115 |
126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01270230 |
127 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00312995 |
128 | MYC_22102868_ChIP-Seq_BL_Human | 1.00207798 |
129 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00171868 |
130 | * MYB_26560356_Chip-Seq_TH2_Human | 0.99853773 |
131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98465042 |
132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98404949 |
133 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98243183 |
134 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98127867 |
135 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97978396 |
136 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97204459 |
137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97074414 |
138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97031714 |
139 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96915161 |
140 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96848440 |
141 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96489425 |
142 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94309157 |
143 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94229684 |
144 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93751216 |
145 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93693184 |
146 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93647362 |
147 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93592040 |
148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92327172 |
149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90837728 |
150 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90567164 |
151 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90430163 |
152 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90162077 |
153 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89315769 |
154 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.89226551 |
155 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.88811641 |
156 | EWS_26573619_Chip-Seq_HEK293_Human | 0.87689816 |
157 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86831139 |
158 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.86370824 |
159 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86302027 |
160 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85995246 |
161 | P68_20966046_ChIP-Seq_HELA_Human | 0.85013228 |
162 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84921229 |
163 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84454933 |
164 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84212452 |
165 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.83456248 |
166 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81786811 |
167 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80261684 |
168 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.79874913 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.68852395 |
2 | MP0002148_abnormal_hypersensitivity_rea | 3.30718689 |
3 | MP0006082_CNS_inflammation | 3.25472802 |
4 | MP0009840_abnormal_foam_cell | 3.21262807 |
5 | MP0006292_abnormal_olfactory_placode | 3.07214460 |
6 | MP0005671_abnormal_response_to | 2.98939125 |
7 | MP0003303_peritoneal_inflammation | 2.91587643 |
8 | MP0000604_amyloidosis | 2.61373883 |
9 | MP0003136_yellow_coat_color | 2.51568772 |
10 | MP0002419_abnormal_innate_immunity | 2.49417023 |
11 | MP0005409_darkened_coat_color | 2.38221355 |
12 | MP0003300_gastrointestinal_ulcer | 2.37161501 |
13 | MP0009785_altered_susceptibility_to | 2.37056900 |
14 | MP0000566_synostosis | 2.33780904 |
15 | MP0005000_abnormal_immune_tolerance | 2.30771594 |
16 | MP0002277_abnormal_respiratory_mucosa | 2.23016091 |
17 | MP0005167_abnormal_blood-brain_barrier | 2.18784083 |
18 | MP0005387_immune_system_phenotype | 2.12560155 |
19 | MP0001790_abnormal_immune_system | 2.12560155 |
20 | MP0002452_abnormal_antigen_presenting | 2.09241613 |
21 | MP0005025_abnormal_response_to | 2.08488923 |
22 | MP0003724_increased_susceptibility_to | 2.06028427 |
23 | MP0003436_decreased_susceptibility_to | 2.03830195 |
24 | MP0008058_abnormal_DNA_repair | 2.02124761 |
25 | MP0001188_hyperpigmentation | 2.00422652 |
26 | MP0005451_abnormal_body_composition | 2.00215708 |
27 | * MP0002723_abnormal_immune_serum | 1.98738120 |
28 | MP0005171_absent_coat_pigmentation | 1.96047596 |
29 | MP0004147_increased_porphyrin_level | 1.92877100 |
30 | MP0002132_abnormal_respiratory_system | 1.92601661 |
31 | MP0001800_abnormal_humoral_immune | 1.90891286 |
32 | MP0001986_abnormal_taste_sensitivity | 1.90479314 |
33 | * MP0001819_abnormal_immune_cell | 1.88724134 |
34 | MP0000015_abnormal_ear_pigmentation | 1.87088764 |
35 | * MP0002420_abnormal_adaptive_immunity | 1.85830630 |
36 | MP0003828_pulmonary_edema | 1.84976182 |
37 | MP0005464_abnormal_platelet_physiology | 1.80108930 |
38 | MP0005646_abnormal_pituitary_gland | 1.76229425 |
39 | MP0005075_abnormal_melanosome_morpholog | 1.73936726 |
40 | MP0005645_abnormal_hypothalamus_physiol | 1.68629795 |
41 | MP0003172_abnormal_lysosome_physiology | 1.67450407 |
42 | MP0004782_abnormal_surfactant_physiolog | 1.66892744 |
43 | MP0005058_abnormal_lysosome_morphology | 1.66800541 |
44 | MP0004510_myositis | 1.57347861 |
45 | MP0009278_abnormal_bone_marrow | 1.52845231 |
46 | MP0002405_respiratory_system_inflammati | 1.52512251 |
47 | MP0003329_amyloid_beta_deposits | 1.52062500 |
48 | MP0004381_abnormal_hair_follicle | 1.44396152 |
49 | MP0008007_abnormal_cellular_replicative | 1.43495693 |
50 | MP0005174_abnormal_tail_pigmentation | 1.43465597 |
51 | MP0005310_abnormal_salivary_gland | 1.42696121 |
52 | MP0003787_abnormal_imprinting | 1.42501113 |
53 | MP0002396_abnormal_hematopoietic_system | 1.39555457 |
54 | MP0003763_abnormal_thymus_physiology | 1.36413430 |
55 | MP0001545_abnormal_hematopoietic_system | 1.36360159 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.36360159 |
57 | MP0008057_abnormal_DNA_replication | 1.36177270 |
58 | MP0000716_abnormal_immune_system | 1.32060740 |
59 | MP0001853_heart_inflammation | 1.31694330 |
60 | MP0000685_abnormal_immune_system | 1.28791276 |
61 | MP0002638_abnormal_pupillary_reflex | 1.28448914 |
62 | MP0002398_abnormal_bone_marrow | 1.24147303 |
63 | MP0001542_abnormal_bone_strength | 1.21817464 |
64 | MP0000858_altered_metastatic_potential | 1.21376070 |
65 | MP0003183_abnormal_peptide_metabolism | 1.17092162 |
66 | MP0005166_decreased_susceptibility_to | 1.16306607 |
67 | MP0002095_abnormal_skin_pigmentation | 1.13908173 |
68 | MP0002876_abnormal_thyroid_physiology | 1.13698611 |
69 | MP0004142_abnormal_muscle_tone | 1.13587403 |
70 | MP0002009_preneoplasia | 1.12858063 |
71 | MP0009333_abnormal_splenocyte_physiolog | 1.11795336 |
72 | MP0001845_abnormal_inflammatory_respons | 1.11364055 |
73 | MP0003634_abnormal_glial_cell | 1.08969894 |
74 | MP0001533_abnormal_skeleton_physiology | 1.08391572 |
75 | MP0000920_abnormal_myelination | 1.08159302 |
76 | MP0002998_abnormal_bone_remodeling | 1.05841729 |
77 | MP0009764_decreased_sensitivity_to | 1.03510710 |
78 | MP0000465_gastrointestinal_hemorrhage | 1.03072014 |
79 | MP0002429_abnormal_blood_cell | 1.02905513 |
80 | MP0000372_irregular_coat_pigmentation | 1.01892103 |
81 | MP0004883_abnormal_blood_vessel | 1.00921367 |
82 | MP0008877_abnormal_DNA_methylation | 0.98491000 |
83 | MP0000689_abnormal_spleen_morphology | 0.97229134 |
84 | MP0001873_stomach_inflammation | 0.96585778 |
85 | MP0000681_abnormal_thyroid_gland | 0.96511322 |
86 | MP0005365_abnormal_bile_salt | 0.96425900 |
87 | MP0008469_abnormal_protein_level | 0.95712833 |
88 | MP0002006_tumorigenesis | 0.95452037 |
89 | MP0004947_skin_inflammation | 0.95424560 |
90 | MP0002139_abnormal_hepatobiliary_system | 0.95268986 |
91 | MP0010386_abnormal_urinary_bladder | 0.94738926 |
92 | MP0002933_joint_inflammation | 0.94020569 |
93 | MP0002090_abnormal_vision | 0.93860864 |
94 | MP0005410_abnormal_fertilization | 0.93557244 |
95 | MP0003633_abnormal_nervous_system | 0.92544018 |
96 | MP0010155_abnormal_intestine_physiology | 0.91357313 |
97 | MP0008260_abnormal_autophagy | 0.90792119 |
98 | MP0003690_abnormal_glial_cell | 0.90715039 |
99 | MP0005165_increased_susceptibility_to | 0.90332907 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.90025445 |
101 | MP0003879_abnormal_hair_cell | 0.89429526 |
102 | MP0005670_abnormal_white_adipose | 0.88113475 |
103 | MP0002722_abnormal_immune_system | 0.86816922 |
104 | MP0001851_eye_inflammation | 0.84762570 |
105 | MP0009697_abnormal_copulation | 0.84668929 |
106 | MP0003806_abnormal_nucleotide_metabolis | 0.84392223 |
107 | MP0000490_abnormal_crypts_of | 0.83647466 |
108 | MP0001663_abnormal_digestive_system | 0.81496986 |
109 | MP0003795_abnormal_bone_structure | 0.80745043 |
110 | MP0000343_altered_response_to | 0.80667028 |
111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79887626 |
112 | MP0003632_abnormal_nervous_system | 0.79650644 |
113 | MP0008004_abnormal_stomach_pH | 0.78709256 |
114 | MP0000249_abnormal_blood_vessel | 0.78587961 |
115 | MP0001849_ear_inflammation | 0.76038919 |
116 | MP0008789_abnormal_olfactory_epithelium | 0.75828702 |
117 | MP0003943_abnormal_hepatobiliary_system | 0.75807171 |
118 | MP0003786_premature_aging | 0.74480108 |
119 | MP0003075_altered_response_to | 0.73842667 |
120 | MP0001186_pigmentation_phenotype | 0.73536498 |
121 | MP0002138_abnormal_hepatobiliary_system | 0.73135761 |
122 | MP0009763_increased_sensitivity_to | 0.72821155 |
123 | MP0002971_abnormal_brown_adipose | 0.71305887 |
124 | MP0005390_skeleton_phenotype | 0.71107173 |
125 | MP0003866_abnormal_defecation | 0.70985903 |
126 | MP0005164_abnormal_response_to | 0.70267270 |
127 | MP0003279_aneurysm | 0.70151385 |
128 | MP0005377_hearing/vestibular/ear_phenot | 0.69855276 |
129 | MP0003878_abnormal_ear_physiology | 0.69855276 |
130 | MP0000383_abnormal_hair_follicle | 0.69273889 |
131 | MP0003631_nervous_system_phenotype | 0.68693726 |
132 | MP0001984_abnormal_olfaction | 0.68607652 |
133 | MP0002254_reproductive_system_inflammat | 0.68605610 |
134 | MP0003448_altered_tumor_morphology | 0.68373394 |
135 | MP0003950_abnormal_plasma_membrane | 0.67600283 |
136 | MP0010094_abnormal_chromosome_stability | 0.67272042 |
137 | MP0002229_neurodegeneration | 0.67120814 |
138 | MP0003191_abnormal_cellular_cholesterol | 0.66630506 |
139 | MP0002166_altered_tumor_susceptibility | 0.64797223 |
140 | MP0004742_abnormal_vestibular_system | 0.64329734 |
141 | MP0009115_abnormal_fat_cell | 0.61251320 |
142 | MP0002896_abnormal_bone_mineralization | 0.60610784 |
143 | MP0005595_abnormal_vascular_smooth | 0.60162009 |
144 | MP0008874_decreased_physiological_sensi | 0.59271437 |
145 | MP0010307_abnormal_tumor_latency | 0.58439915 |
146 | MP0003011_delayed_dark_adaptation | 0.56474668 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Disinhibition (HP:0000734) | 5.36175554 |
2 | Dysostosis multiplex (HP:0000943) | 4.91658760 |
3 | Mutism (HP:0002300) | 4.88086719 |
4 | Recurrent abscess formation (HP:0002722) | 4.68001443 |
5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.50368057 |
6 | Axonal loss (HP:0003447) | 4.46990847 |
7 | Spontaneous hematomas (HP:0007420) | 4.45389747 |
8 | Recurrent bacterial skin infections (HP:0005406) | 4.30491716 |
9 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.28771497 |
10 | Complement deficiency (HP:0004431) | 4.13868491 |
11 | Chromsome breakage (HP:0040012) | 4.03185572 |
12 | Loss of speech (HP:0002371) | 4.02550702 |
13 | Upper motor neuron abnormality (HP:0002127) | 3.94852749 |
14 | Abnormality of complement system (HP:0005339) | 3.77435534 |
15 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.72398137 |
16 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.72398137 |
17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.72398137 |
18 | Duplicated collecting system (HP:0000081) | 3.55340840 |
19 | Eczematoid dermatitis (HP:0000976) | 3.53957922 |
20 | Mucopolysacchariduria (HP:0008155) | 3.52476066 |
21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.52476066 |
22 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.43900351 |
23 | Abnormality of the renal collecting system (HP:0004742) | 3.40483532 |
24 | Neurofibrillary tangles (HP:0002185) | 3.39145768 |
25 | Methylmalonic acidemia (HP:0002912) | 3.26023714 |
26 | Optic neuritis (HP:0100653) | 3.24725491 |
27 | Retrobulbar optic neuritis (HP:0100654) | 3.24725491 |
28 | Retinal atrophy (HP:0001105) | 3.20724182 |
29 | Recurrent skin infections (HP:0001581) | 3.20240236 |
30 | Inappropriate behavior (HP:0000719) | 3.14478595 |
31 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.12550933 |
32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.12550933 |
33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.12550933 |
34 | Nephritis (HP:0000123) | 3.08279578 |
35 | Systemic lupus erythematosus (HP:0002725) | 3.03978938 |
36 | Nuclear cataract (HP:0100018) | 2.98919142 |
37 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.97099207 |
38 | Neuronal loss in central nervous system (HP:0002529) | 2.90486729 |
39 | Personality changes (HP:0000751) | 2.90154977 |
40 | Purpura (HP:0000979) | 2.78401462 |
41 | Hematochezia (HP:0002573) | 2.76065698 |
42 | Pathologic fracture (HP:0002756) | 2.73987407 |
43 | Obstructive lung disease (HP:0006536) | 2.72721692 |
44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72721692 |
45 | Orchitis (HP:0100796) | 2.71195849 |
46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65897841 |
47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65897841 |
48 | Amyloidosis (HP:0011034) | 2.65661747 |
49 | Myositis (HP:0100614) | 2.62786404 |
50 | Chronic otitis media (HP:0000389) | 2.58853271 |
51 | Hemoptysis (HP:0002105) | 2.53795270 |
52 | Chronic diarrhea (HP:0002028) | 2.50404132 |
53 | Clubbing of toes (HP:0100760) | 2.47987480 |
54 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.47615059 |
55 | Prostate neoplasm (HP:0100787) | 2.47384522 |
56 | Apathy (HP:0000741) | 2.46635887 |
57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45322773 |
58 | Abnormality of macrophages (HP:0004311) | 2.44875043 |
59 | Type I transferrin isoform profile (HP:0003642) | 2.44204284 |
60 | Diminished motivation (HP:0000745) | 2.42672416 |
61 | True hermaphroditism (HP:0010459) | 2.40905383 |
62 | Petechiae (HP:0000967) | 2.39883027 |
63 | Dementia (HP:0000726) | 2.39465502 |
64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39262841 |
65 | Recurrent fungal infections (HP:0002841) | 2.38673333 |
66 | Abnormality of DNA repair (HP:0003254) | 2.37351061 |
67 | Global brain atrophy (HP:0002283) | 2.37123447 |
68 | Asymmetric septal hypertrophy (HP:0001670) | 2.35412933 |
69 | Progressive visual loss (HP:0000529) | 2.34831371 |
70 | Cerebral inclusion bodies (HP:0100314) | 2.34242815 |
71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33878202 |
72 | Duplication of thumb phalanx (HP:0009942) | 2.32904802 |
73 | White forelock (HP:0002211) | 2.32770094 |
74 | Autoimmune thrombocytopenia (HP:0001973) | 2.30456124 |
75 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.28563052 |
76 | Septo-optic dysplasia (HP:0100842) | 2.27709730 |
77 | Peripheral demyelination (HP:0011096) | 2.27423491 |
78 | Glomerulonephritis (HP:0000099) | 2.27271350 |
79 | Hypoplasia of the fovea (HP:0007750) | 2.26278500 |
80 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.26278500 |
81 | Intestinal atresia (HP:0011100) | 2.25098777 |
82 | Pustule (HP:0200039) | 2.25055383 |
83 | Abnormality of vitamin B metabolism (HP:0004340) | 2.25034533 |
84 | Mediastinal lymphadenopathy (HP:0100721) | 2.24577978 |
85 | Basal ganglia calcification (HP:0002135) | 2.23226636 |
86 | Patchy hypopigmentation of hair (HP:0011365) | 2.23191123 |
87 | Meningitis (HP:0001287) | 2.22093752 |
88 | Progressive neurologic deterioration (HP:0002344) | 2.20525727 |
89 | Prolonged bleeding time (HP:0003010) | 2.20509315 |
90 | Recurrent pneumonia (HP:0006532) | 2.16171318 |
91 | Abnormality of the preputium (HP:0100587) | 2.15311954 |
92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14058195 |
93 | Pancreatic fibrosis (HP:0100732) | 2.11390608 |
94 | Ectopic kidney (HP:0000086) | 2.09074652 |
95 | Reduced antithrombin III activity (HP:0001976) | 2.07133429 |
96 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05802758 |
97 | Thoracic kyphosis (HP:0002942) | 2.04870119 |
98 | Conjunctival telangiectasia (HP:0000524) | 2.04594892 |
99 | Vasculitis (HP:0002633) | 2.04307293 |
100 | Homocystinuria (HP:0002156) | 2.03652443 |
101 | Abnormality of homocysteine metabolism (HP:0010919) | 2.03652443 |
102 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.02348351 |
103 | Memory impairment (HP:0002354) | 2.02227097 |
104 | Stomatitis (HP:0010280) | 2.02011909 |
105 | Recurrent viral infections (HP:0004429) | 2.01451417 |
106 | Aplasia cutis congenita (HP:0001057) | 1.99562303 |
107 | Acrocyanosis (HP:0001063) | 1.98608638 |
108 | Abnormal hair whorl (HP:0010721) | 1.98500773 |
109 | Vertebral compression fractures (HP:0002953) | 1.96296663 |
110 | Bone marrow hypocellularity (HP:0005528) | 1.95870236 |
111 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95339914 |
112 | Gingivitis (HP:0000230) | 1.94428280 |
113 | Abnormality of the fovea (HP:0000493) | 1.94317937 |
114 | Agnosia (HP:0010524) | 1.93477706 |
115 | Optic nerve hypoplasia (HP:0000609) | 1.93447844 |
116 | Polyneuropathy (HP:0001271) | 1.93224963 |
117 | Abnormality of the nasal mucosa (HP:0000433) | 1.92019635 |
118 | Increased CSF protein (HP:0002922) | 1.91433336 |
119 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.91187318 |
120 | Increased serum ferritin (HP:0003281) | 1.90962577 |
121 | Abnormality of the prostate (HP:0008775) | 1.90824924 |
122 | Cardiomegaly (HP:0001640) | 1.90542184 |
123 | Urticaria (HP:0001025) | 1.90522930 |
124 | Aplastic anemia (HP:0001915) | 1.90049028 |
125 | Meckel diverticulum (HP:0002245) | 1.89676270 |
126 | Increased IgM level (HP:0003496) | 1.88550051 |
127 | Myocardial infarction (HP:0001658) | 1.88500141 |
128 | Methylmalonic aciduria (HP:0012120) | 1.88382366 |
129 | Hepatosplenomegaly (HP:0001433) | 1.88353818 |
130 | Epistaxis (HP:0000421) | 1.88013779 |
131 | Bone pain (HP:0002653) | 1.87985828 |
132 | Neutropenia (HP:0001875) | 1.87894236 |
133 | Restrictive lung disease (HP:0002091) | 1.87730422 |
134 | Urethral obstruction (HP:0000796) | 1.85126609 |
135 | Abnormality of the ileum (HP:0001549) | 1.84917618 |
136 | Cellulitis (HP:0100658) | 1.84073822 |
137 | Renal cortical cysts (HP:0000803) | 1.84028560 |
138 | Abnormal glycosylation (HP:0012345) | 1.83847077 |
139 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83847077 |
140 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83847077 |
141 | Abnormal protein glycosylation (HP:0012346) | 1.83847077 |
142 | Abnormality of the periventricular white matter (HP:0002518) | 1.82901470 |
143 | Abnormality of incisor morphology (HP:0011063) | 1.82640507 |
144 | Supranuclear gaze palsy (HP:0000605) | 1.82254961 |
145 | Bone cyst (HP:0012062) | 1.81804877 |
146 | Increased cerebral lipofuscin (HP:0011813) | 1.80759044 |
147 | Vacuolated lymphocytes (HP:0001922) | 1.80312471 |
148 | Pulmonary infiltrates (HP:0002113) | 1.79710062 |
149 | Encephalitis (HP:0002383) | 1.78501876 |
150 | Stomach cancer (HP:0012126) | 1.77334372 |
151 | Type 2 muscle fiber atrophy (HP:0003554) | 1.77100619 |
152 | Abnormality of chromosome stability (HP:0003220) | 1.76538788 |
153 | Xerostomia (HP:0000217) | 1.76495936 |
154 | Leukopenia (HP:0001882) | 1.76458272 |
155 | IgM deficiency (HP:0002850) | 1.76049290 |
156 | Prolonged neonatal jaundice (HP:0006579) | 1.75277469 |
157 | Keratoconjunctivitis sicca (HP:0001097) | 1.74979310 |
158 | Spondylolisthesis (HP:0003302) | 1.72930644 |
159 | Pulmonary embolism (HP:0002204) | 1.72778610 |
160 | Panhypogammaglobulinemia (HP:0003139) | 1.71574016 |
161 | Cheilitis (HP:0100825) | 1.70751908 |
162 | Diplopia (HP:0000651) | 1.70045625 |
163 | Abnormality of binocular vision (HP:0011514) | 1.70045625 |
164 | Renal Fanconi syndrome (HP:0001994) | 1.69354230 |
165 | Urinary incontinence (HP:0000020) | 1.68356948 |
166 | Premature loss of primary teeth (HP:0006323) | 1.65789022 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK3 | 3.62486363 |
2 | IRAK4 | 3.45734059 |
3 | CAMK1D | 3.03595008 |
4 | TXK | 2.97243279 |
5 | MAP3K14 | 2.91792413 |
6 | ERN1 | 2.65826038 |
7 | TNIK | 2.40795914 |
8 | ZAK | 2.40727022 |
9 | STK4 | 2.32794126 |
10 | BMPR1B | 2.22853917 |
11 | GRK7 | 2.19703453 |
12 | STK16 | 2.16488425 |
13 | CAMK1G | 2.09582306 |
14 | MAP3K13 | 2.07340773 |
15 | TGFBR2 | 1.99597791 |
16 | MKNK2 | 1.93102121 |
17 | CAMKK1 | 1.91577976 |
18 | FGR | 1.87830432 |
19 | CASK | 1.86273745 |
20 | BMPR2 | 1.86198775 |
21 | EIF2AK2 | 1.82748014 |
22 | TGFBR1 | 1.81635479 |
23 | TRPM7 | 1.80628280 |
24 | MAP3K11 | 1.76142290 |
25 | CLK1 | 1.73630579 |
26 | STK3 | 1.71684470 |
27 | BLK | 1.70132565 |
28 | VRK1 | 1.69345848 |
29 | KIT | 1.62950987 |
30 | IKBKB | 1.62546463 |
31 | NEK6 | 1.61535142 |
32 | TNK2 | 1.53382500 |
33 | SRPK1 | 1.51159361 |
34 | TEC | 1.49081272 |
35 | MAPK15 | 1.47660896 |
36 | FES | 1.47391801 |
37 | SIK3 | 1.45555913 |
38 | MAP4K1 | 1.43140561 |
39 | IKBKE | 1.42865420 |
40 | MKNK1 | 1.38745721 |
41 | ADRBK2 | 1.37947485 |
42 | TESK1 | 1.37717031 |
43 | ERBB3 | 1.33186588 |
44 | NME2 | 1.33134856 |
45 | TYK2 | 1.32235682 |
46 | DDR2 | 1.31988800 |
47 | MAP2K3 | 1.30792796 |
48 | PRPF4B | 1.27107180 |
49 | TESK2 | 1.22329358 |
50 | EIF2AK3 | 1.19527182 |
51 | YES1 | 1.18799590 |
52 | CSF1R | 1.18318136 |
53 | DAPK2 | 1.14604692 |
54 | CDK3 | 1.13410078 |
55 | ABL2 | 1.10163226 |
56 | RIPK4 | 1.08910374 |
57 | EPHB1 | 1.04395018 |
58 | PDPK1 | 1.04322747 |
59 | MAP3K3 | 1.03283416 |
60 | GRK1 | 1.02834270 |
61 | LYN | 1.01574370 |
62 | CDC42BPA | 0.99458500 |
63 | JAK2 | 0.97986451 |
64 | TSSK6 | 0.97469235 |
65 | TBK1 | 0.97412211 |
66 | PBK | 0.96410392 |
67 | ACVR1B | 0.94940283 |
68 | PIK3CG | 0.93195641 |
69 | PDK1 | 0.91860492 |
70 | CHUK | 0.88935616 |
71 | CDK8 | 0.87726877 |
72 | MAP3K1 | 0.87349989 |
73 | BTK | 0.87246217 |
74 | NUAK1 | 0.85423359 |
75 | MOS | 0.85092930 |
76 | SIK2 | 0.85009771 |
77 | CDK6 | 0.84869149 |
78 | RIPK1 | 0.84375738 |
79 | INSRR | 0.83545860 |
80 | PKN1 | 0.83091975 |
81 | SYK | 0.82922342 |
82 | BRD4 | 0.82746093 |
83 | TAOK1 | 0.80372644 |
84 | CSK | 0.80073774 |
85 | SGK2 | 0.79841480 |
86 | ITK | 0.76851056 |
87 | MARK2 | 0.76607278 |
88 | JAK3 | 0.74578656 |
89 | PLK4 | 0.72748100 |
90 | CAMK4 | 0.72461537 |
91 | MAPK13 | 0.72374102 |
92 | MST4 | 0.71575517 |
93 | KSR2 | 0.70671178 |
94 | IRAK2 | 0.69756185 |
95 | STK24 | 0.69493685 |
96 | IRAK1 | 0.67883917 |
97 | LCK | 0.66889477 |
98 | HCK | 0.65073007 |
99 | TAOK2 | 0.63560840 |
100 | JAK1 | 0.63347454 |
101 | MAPK7 | 0.62968156 |
102 | MARK3 | 0.62560507 |
103 | PRKD2 | 0.61425684 |
104 | PRKG2 | 0.60939758 |
105 | BCR | 0.59714476 |
106 | EPHB2 | 0.57690322 |
107 | RPS6KA2 | 0.55001803 |
108 | MAP2K7 | 0.54935929 |
109 | TLK1 | 0.54109563 |
110 | EIF2AK1 | 0.54040351 |
111 | PIM2 | 0.53991092 |
112 | CDK19 | 0.53799128 |
113 | PIM1 | 0.53185643 |
114 | PRKCE | 0.52231824 |
115 | MAPKAPK5 | 0.51567113 |
116 | PRKCQ | 0.51268054 |
117 | MATK | 0.50941414 |
118 | RPS6KA5 | 0.50041202 |
119 | ATR | 0.49285953 |
120 | CAMK1 | 0.48369280 |
121 | PAK4 | 0.48311129 |
122 | SGK3 | 0.47732019 |
123 | MAP3K2 | 0.47406063 |
124 | TRIB3 | 0.47103837 |
125 | RPS6KL1 | 0.46805214 |
126 | RPS6KC1 | 0.46805214 |
127 | TAOK3 | 0.45089794 |
128 | SGK494 | 0.44281340 |
129 | SGK223 | 0.44281340 |
130 | MAPK12 | 0.42573439 |
131 | RPS6KA6 | 0.42546614 |
132 | MAPKAPK2 | 0.42485489 |
133 | FYN | 0.42116299 |
134 | TIE1 | 0.41810231 |
135 | PRKCD | 0.41656578 |
136 | NLK | 0.41418100 |
137 | ARAF | 0.40830196 |
138 | PINK1 | 0.39126785 |
139 | ZAP70 | 0.39098544 |
140 | AKT3 | 0.37504811 |
141 | EPHA3 | 0.36213154 |
142 | ABL1 | 0.36056343 |
143 | NEK9 | 0.35850314 |
144 | CDK4 | 0.34323913 |
145 | PRKAA2 | 0.32249403 |
146 | MAP2K4 | 0.30459301 |
147 | PDK2 | 0.29263785 |
148 | CAMKK2 | 0.28997786 |
149 | MAP2K6 | 0.27927231 |
150 | PRKD1 | 0.27651160 |
151 | DYRK1B | 0.27404601 |
152 | IGF1R | 0.26203757 |
153 | KSR1 | 0.24801731 |
154 | RET | 0.24689639 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.66845526 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.50168494 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.49074060 |
4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.48195975 |
5 | Asthma_Homo sapiens_hsa05310 | 2.35390719 |
6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.20987129 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12130314 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05193637 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 1.99111682 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96750889 |
11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.89333510 |
12 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.79873515 |
13 | Measles_Homo sapiens_hsa05162 | 1.77292260 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72777165 |
15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72162089 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70998741 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69486170 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66373183 |
19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65187538 |
20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65116083 |
21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62949224 |
22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54984206 |
23 | Protein export_Homo sapiens_hsa03060 | 1.52321647 |
24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52220346 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.48217313 |
26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47281230 |
27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46125289 |
28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.44944372 |
29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.43691536 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.39127157 |
31 | Homologous recombination_Homo sapiens_hsa03440 | 1.38417257 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33516807 |
33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33025374 |
34 | RNA polymerase_Homo sapiens_hsa03020 | 1.28783697 |
35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.28355790 |
36 | Malaria_Homo sapiens_hsa05144 | 1.27429054 |
37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22012047 |
38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20745629 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 1.19724948 |
40 | Legionellosis_Homo sapiens_hsa05134 | 1.18394825 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.16180760 |
42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14874280 |
43 | Phagosome_Homo sapiens_hsa04145 | 1.12777109 |
44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12513129 |
45 | Base excision repair_Homo sapiens_hsa03410 | 1.10623968 |
46 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08978965 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07384496 |
48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07091044 |
49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.07020559 |
50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06190046 |
51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02355985 |
52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02204395 |
53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00800244 |
54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99262924 |
55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89430017 |
56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86818496 |
57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86766490 |
58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85593336 |
59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84197107 |
60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83973170 |
61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81390780 |
62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79742351 |
63 | Mineral absorption_Homo sapiens_hsa04978 | 0.79718418 |
64 | Platelet activation_Homo sapiens_hsa04611 | 0.79438116 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78319581 |
66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78177447 |
67 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77705686 |
68 | DNA replication_Homo sapiens_hsa03030 | 0.76954157 |
69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76166470 |
70 | Endocytosis_Homo sapiens_hsa04144 | 0.74361404 |
71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73527205 |
72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72275538 |
73 | Salmonella infection_Homo sapiens_hsa05132 | 0.71956701 |
74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71863637 |
75 | Apoptosis_Homo sapiens_hsa04210 | 0.67719930 |
76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67687539 |
77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65157140 |
78 | Mismatch repair_Homo sapiens_hsa03430 | 0.63565147 |
79 | Shigellosis_Homo sapiens_hsa05131 | 0.62392520 |
80 | Hepatitis B_Homo sapiens_hsa05161 | 0.60362948 |
81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58793775 |
82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58482051 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56569921 |
84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56556326 |
85 | Amoebiasis_Homo sapiens_hsa05146 | 0.56398706 |
86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55613015 |
87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54557318 |
88 | Hepatitis C_Homo sapiens_hsa05160 | 0.53841886 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52920679 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51860184 |
91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51688980 |
92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49926180 |
93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49634865 |
94 | ABC transporters_Homo sapiens_hsa02010 | 0.49498677 |
95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49177291 |
96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49072613 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.48066245 |
98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47886928 |
99 | Purine metabolism_Homo sapiens_hsa00230 | 0.47779324 |
100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46742295 |
101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45921240 |
102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42867636 |
103 | RNA degradation_Homo sapiens_hsa03018 | 0.42101674 |
104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41965488 |
105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40264765 |
106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39848762 |
107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39103512 |
108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38931117 |
109 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.38850695 |
110 | Spliceosome_Homo sapiens_hsa03040 | 0.38835346 |
111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37915439 |
112 | Proteasome_Homo sapiens_hsa03050 | 0.36863037 |
113 | Nicotine addiction_Homo sapiens_hsa05033 | 0.36077369 |
114 | Renin secretion_Homo sapiens_hsa04924 | 0.34454794 |
115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33817165 |
116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33665722 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33642918 |
118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33531651 |
119 | Morphine addiction_Homo sapiens_hsa05032 | 0.31987330 |
120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31272779 |
121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31249384 |
122 | Bladder cancer_Homo sapiens_hsa05219 | 0.30815262 |
123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30597279 |
124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30489252 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30054903 |
126 | Phototransduction_Homo sapiens_hsa04744 | 0.29905746 |
127 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28926185 |
128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27887064 |
129 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26598332 |
130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26323122 |
131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24829223 |
132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24474130 |
133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24452201 |
134 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24364553 |
135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22784134 |
136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22477623 |
137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19598966 |
138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19356886 |
139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18401235 |
140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17790906 |